BILLS-116hr4764rds.pdf

23:02 Jan 04 2020 2005 2025 less than every two years OCTOBER 1, 2020 each of fiscal years 42 U.S.C. 274k(d)(2 fiscal year 2015 8 each of fiscal years 2016 each of fiscal years 2021 September 30 each calendar year later than 2 years 2015 20 June 30, 2024

SESSION H. R. 4764 the ‘‘Timely ReAuthoriza-

PO 00000 Frm 00004 PO 00000 Frm 00002 PO 00000 Frm 00006 PO 00000 Frm 00005 PO 00000 Frm 00007 PO 00000 Frm 00003 Fmt PO 00000 Frm 00001

THE UNITED STATES the United States of America

the Stem Cell Therapeutic and Research Act

APPROPRIATIONS.—To

DSK79L0C42PROD the Public Health Service Act SEC Senate Labor the House of Representatives U.S.C. Committee the Committee on Health, Education Advisory Energy and Commerce Institutes of Health Congress Resources and Services Administration Transplantation Program the Stem Cell Therapeutic and Research Reauthor- THE FIELD OF REGENERATIVE House of Representa- the National Institutes of Health the Comptroller General ADVISORY COUNCIL Programs Lends Access National House Drug Administration Food and Drugs GAO Health Program NIH

kjohnson CHERYL L. JOHNSON

stem cell cell stem bills rds rds therapies rds kjohnson cells therapeutic advisory council blood tissue institutes section public medicine